Product
Tocotrienol
1 clinical trial
3 indications
Indication
End-Stage Liver DiseaseIndication
Nonalcoholic SteatohepatitisIndication
Nonalcoholic Fatty Liver DiseaseClinical trial
Tocotrienol Against the Progression of End Stage Liver DiseaseStatus: Recruiting, Estimated PCD: 2028-12-31